Nice | Type 2 diabetes in adults

12th April 2016 by Louise Hudman

Nice | Type 2 diabetes in adults

This is an update of the last Nice guideline on type 2 diabetes in adults, which was published in 2009. I am just summarising things that have changed since the last update. If you don’t want to read anything else, just be aware that Nice has produced an excellent single A4 summary of what drugs to use when.

HbA1C targets for Type 2 diabetes

Nice advise that these targets can be tailored to the patient. They also advise that the targets can be relaxed if the side-effects from medications, or if the effort to reach that target impairs their quality of life.

  • 48 mmol/mol (6.5%) = target for people just managed with lifestyle or on a single drug which doesn’t cause hypoglycaemia.
  • 53 mm0l/mol (7%) = target for people on drugs which cause hypoglycaemia.
  • 58 mmol/mol (7.5%) or above:
    • Offer encouragement
    • Lifestyle advice
    • Intensify drug treatment

BM testing

This is largely the same and the differences are subtle. Nice no longer advising doing BMs routinely twice a week. They also no longer advise monitoring with illness, though they do acknowledge that you need to be aware of the risk of hyperglycaemia with illness. Previously they advised monitoring if on oral medication that could cause hypos, but now they only advise testing if they are also driving or operating machinery.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I’m loving LocumDeck, it’s a great piece of software."

Dr David Williams

Dr David Williams

See the full list of features within our NASGP membership plans

Membership